Janux Therapeutics
Diane Aceveda has worked in the research field for the past two years. Diane began their career in 2019 as a Research Associate at Proteogenomics Research Institute for Systems Medicine (PRISM). In 2021, they moved to Janux Therapeutics, where they currently work as a Senior Research Associate.
Diane Aceveda obtained a Bachelor of Science in Chemistry (Biochemistry) from San Diego State University in 2015, followed by a Master of Science in Chemistry (Chemical Biology) from Colorado State University in 2019.
Janux Therapeutics
1 followers
Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.